SIHWA LEE: Open Payments
NPI 1750090569 · WATKINSVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$594 in 18 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $109 · 2025 $594
Food & beverage: $510Education: $84
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 3 | $160 |
| Phathom Pharmaceuticals, Inc. | 1 | $114 |
| Janssen Biotech, Inc. | 2 | $104 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $53 |
| Novo Nordisk Inc | 2 | $39 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $35 |
| Lucid Diagnostics Inc. | 1 | $19 |
| Ipsen Biopharmaceuticals, Inc | 1 | $19 |
| EVOKE PHARMA, INC. | 1 | $18 |
| Exelixis Inc. | 1 | $17 |
Products named: DUPIXENT, VOQUEZNA, TREMFYA, Wegovy, GATTEX, XIFAXAN, IQIRVO, GIMOTI.
Industry payments across GA — which companies pay providers there.
